tumCV Cancer Research Results
tumCV, Cell Viability: Click to Expand ⟱
| Source: |
| Type: |
Cell Viability
|
Bladder, Bladder Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
tumCV↓, eff↓, Apoptosis↑, Casp3↑, ROS↑, Cyt‑c↑, MMP↓, Bcl-2↓, BAX↑, MOMP↑, TumCG↓,
| - |
vitro+vivo, |
Bladder, |
NA |
|
|
|
tumCV↓, TumCP↓, TumCCA↑, P21↑, p27↑, cycD1/CCND1↓, cycA1/CCNA1↓, CDK2↓, EMT↓, TumMeta↓, p65↓, p‑p65↓, IKKα↓, NF-kB↑, ROS↑, NRF2↓, HO-1↓, SOD2↓, GPx1↓, Bax:Bcl2↑, TumVol↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
tumCV↓, TumCP↓, TumCMig↓, Casp↑, TumAuto↑, LC3B-II↑, p‑AMPK↑, mTOR↓, BMI1↓, ROS↑, eff↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
tumCV↓, selectivity↑, TumCCA↑, other↝, *neuroP↑, *memory↑, *tau↓, *other↝, *lipid-P↓, *VitC↑, *antiOx↑,
| - |
in-vitro, |
Bladder, |
5637 |
|
|
|
tumCV↓, CycB/CCNB1↑, p‑CDK1↑, Apoptosis↑, Casp8↑, Casp9↑, Casp3↑, cl‑PARP↑, ROS↑, eff↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
tumCV↓, Apoptosis↑, Cyt‑c↑, Bax:Bcl2↑, Casp9↑, Casp3↑, Casp8∅, cl‑PARP↑, ROS↑, MMP↓, eff↓, ER Stress↑, p‑NRF2↑, HO-1↑,
| - |
in-vitro, |
Bladder, |
5637 |
|
|
|
- |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
tumCV↓, TumCP↓, TumCI↓, Casp↑, ROS↑, PD-L1↓, EMT↓, MMP↓, eff↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Bladder, |
J82 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
- |
in-vitro, |
Nor, |
L02 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
MMP↓, Cyt‑c↑, Casp3↑, p‑JNK↑, p‑p38↑, ROS↑, eff↓, tumCV↓, selectivity↑, *toxicity↓, TumVol↓,
Showing Research Papers: 1 to 8 of 8
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
GPx1↓, 1, HO-1↓, 1, HO-1↑, 1, NRF2↓, 1, p‑NRF2↑, 1, ROS↑, 7, SOD2↓, 1,
Mitochondria & Bioenergetics ⓘ
MMP↓, 4,
Core Metabolism/Glycolysis ⓘ
p‑AMPK↑, 1,
Cell Death ⓘ
Apoptosis↑, 3, BAX↑, 1, Bax:Bcl2↑, 2, Bcl-2↓, 1, Casp↑, 2, Casp3↑, 4, Casp8↑, 1, Casp8∅, 1, Casp9↑, 2, Cyt‑c↑, 3, p‑JNK↑, 1, MOMP↑, 1, p27↑, 1, p‑p38↑, 1,
Transcription & Epigenetics ⓘ
other↝, 1, tumCV↓, 8,
Protein Folding & ER Stress ⓘ
ER Stress↑, 1,
Autophagy & Lysosomes ⓘ
LC3B-II↑, 1, TumAuto↑, 1,
DNA Damage & Repair ⓘ
cl‑PARP↑, 2,
Cell Cycle & Senescence ⓘ
p‑CDK1↑, 1, CDK2↓, 1, cycA1/CCNA1↓, 1, CycB/CCNB1↑, 1, cycD1/CCND1↓, 1, P21↑, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
BMI1↓, 1, EMT↓, 2, mTOR↓, 1, TumCG↓, 1,
Migration ⓘ
TumCI↓, 1, TumCMig↓, 1, TumCP↓, 3, TumMeta↓, 1,
Immune & Inflammatory Signaling ⓘ
IKKα↓, 1, NF-kB↑, 1, p65↓, 1, p‑p65↓, 1, PD-L1↓, 1,
Drug Metabolism & Resistance ⓘ
eff↓, 6, selectivity↑, 2,
Clinical Biomarkers ⓘ
PD-L1↓, 1,
Functional Outcomes ⓘ
TumVol↓, 2,
Total Targets: 53
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, lipid-P↓, 1, VitC↑, 1,
Transcription & Epigenetics ⓘ
other↝, 1,
Synaptic & Neurotransmission ⓘ
tau↓, 1,
Functional Outcomes ⓘ
memory↑, 1, neuroP↑, 1, toxicity↓, 1,
Total Targets: 8
Scientific Paper Hit Count for: tumCV, Cell Viability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:32 Cells:% prod#:% Target#:897 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page